🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT06505759
Recruiting Phase 1

Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT

NCT06505759 · tracked via the Priya Life Science India tracker
Sponsor
Krishnadevaraya College of Dental Sciences & Hospital
Phase
Phase 1
Started
2024-07-01
Last updated
2025-01-13

Condition(s) studied

Periodontal Pocket

Investigational drug(s) / intervention(s)

Bromelain gelchlorhexidine gelSRP

Bromelain gel: bromelain gel is prepared from bromelain capsules in laboratory

chlorhexidine gel: chlorhexidine gel is prepared from mouth wash

SRP: Scaling and root planing was done with ultra sonic and hand scaling

Study summary

The current study is a prospective randomised study Evaluation of 2%Bromelain Gel With 0.2%Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing in Stage II/III and Grade B Periodontitis

Eligibility

Sex
ALL
Min age
30 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patient with have chronic periodontitis in the age group between 30-50 years. * Patients having ≥20 teeth. -.Patients with radiographic evidence of bone loss in atleast two teeth. * Patients who are systematically healthy. * Patients with localized pockets with probing depth of ≤ 5mm. * Patients who are cooperative and able to attend the hospital for regular follow-up. Exclusion Criteria: * Patients who have received any surgical or nonsurgical therapy during past 6months * Pregnant or lactating females. * Use of systemic antibiotics in the past 6 months. * Patient who are not willing to give a written informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Dr. NALLAGATLA VAMSI VENKATA KRISHNA SAI Bengaluru Karnataka Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06505759 on ClinicalTrials.gov ↗ ← All trials in India